NCM
AGN

Novare Capital Management’s Allergan plc AGN Stock Holding History

Novare Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-23,679
Closed -$4.85M – 160
2017
Q3 		$4.85M Buy
23,679
+65
+0.3% +$15.1K 0.85% 50
2017
Q2 		$5.74M Buy
23,614
+249
+1% +$58.5K 1.29% 32
2017
Q1 		$5.58M Buy
23,365
+312
+1% +$72.7K 1.29% 32
2016
Q4 		$4.84M Sell
23,053
-732
-3% -$152K 1.19% 36
2016
Q3 		$5.48M Buy
23,785
+324
+1% +$79.2K 1.43% 23
2016
Q2 		$5.42M Buy
23,461
+2,383
+11% +$549K 1.46% 21
2016
Q1 		$5.65M Sell
21,078
-2,089
-9% -$598K 1.59% 21
2015
Q4 		$7.24M Buy
23,167
+776
+3% +$231K 1.98% 11
2015
Q3 		$6.09M Sell
22,391
-190
-0.8% -$58.4K 1.68% 18
2015
Q2 		$6.85M Sell
22,581
-292
-1% -$87.1K 1.69% 19
2015
Q1 		$6.81M Sell
22,873
-135
-0.6% -$38.5K 1.68% 19
2014
Q4 		$5.92M Buy
23,008
+1,563
+7% +$391K 1.47% 26
2014
Q3 		$5.17M Buy
+21,445
New +$4.8M 1.27% 33

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Novare Capital Management's AGN Position: Q4 2017 in Review

Novare Capital Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 23,679 shares — an estimated $4.85M sold.

Novare Capital Management first reported a position in AGN in Q3 2014 and held it in 13 quarters. The position peaked at $7.24M in Q4 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Novare Capital Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Novare Capital Management sold 23,679 Allergan plc shares in Q4 2017, an estimated $4.85M.
  • Novare Capital Management first reported a position in Allergan plc in Q3 2014 and held it in 13 quarters.
  • Novare Capital Management's Allergan plc position peaked at $7.24M in Q4 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Novare Capital Management's 13F filing for Q4 2017, filed 6 Feb 2018.